{"id":"W4400272727","doi":"10.1200/jco.2024.42.16_suppl.tps5637","title":"Efficacy and safety of luveltamab tazevibulin vs investigator’s choice of chemotherapy in patients with recurrent platinum-resistant ovarian cancer (PROC) expressing folate receptor alpha (FRα): The REFRaME-01 (GOG-3086, ENGOT-79ov, and APGOT-OV9) phase 2/3 study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Internal medicine; Oncology; Alpha (finance); Gynecology; Cancer; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009762759,0.0005554744,0.001536211,0.0003803375,0.0001757327,0.0008177531,0.0005288382,0.0009536993,0.002531422],"category_scores_gemma":[0.001333637,0.0003339282,0.001194794,0.000299507,0.0005635284,0.0009112491,0.0002664896,0.002277736,0.0005286658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008908682,"about_ca_system_score_gemma":0.0006528315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006214583,"about_ca_topic_score_gemma":0.00166083,"domain_scores_codex":[0.9996492,0.0001725567,0.00001750373,0.00006133186,0.00003326837,0.00006612609],"domain_scores_gemma":[0.9993616,0.0001566122,0.0001626653,0.00004967674,0.0000264737,0.0002431211],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8323429,0.01284676,0.007014291,0.0003942531,0.00120682,0.0001063424,0.0001655652,0.002304817,0.01219451,0.0002020215,0.001713719,0.129508],"study_design_scores_gemma":[0.3760021,0.5796363,0.03001944,0.00007627506,0.001255608,0.0003707078,0.0001161728,0.004567942,0.003877393,0.0005105566,0.003507366,0.00006006897],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950754,0.00296474,0.0001758099,0.0002963318,0.0000850264,0.0002149225,0.0002927876,0.00004392867,0.0008511476],"genre_scores_gemma":[0.9971608,0.0008792974,0.0002338368,0.0002530987,0.00008205995,0.0002142801,0.0004102067,0.00001224081,0.0007542704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002531422,"threshold_uncertainty_score":0.00846839,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06098242071726315,"score_gpt":0.4294056325233429,"score_spread":0.3684232118060797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}